Cancer Drug MRP Rs 27K, Retail Price Rs 2.7K: Supreme Court Questions 10X Gap

The Supreme Court has raised serious questions about the significant price discrepancies in the prices of medicines used to treat serious diseases like cancer. The court heard a case in which the Price to Retail (PTR) of a cancer drug was reported as Rs 2,700, while the MRP was Rs 27,000. This means there was a nearly 10-fold difference between the retail price and the MRP. A two-judge bench of the Supreme Court expressed serious concern over this discrepancy and asked why there was no price con